Literature DB >> 11993941

PET quantitation and imaging of the non-pure positron-emitting iodine isotope 124I.

H Herzog1, L Tellman, S M Qaim, S Spellerberg, A Schmid, H H Coenen.   

Abstract

A series of PET studies using phantoms is presented to characterize the imaging and quantitative performance of the positron-emitting iodine isotope 124I. Measurements were performed on the 2D-PET scanner GE 4096+ as well as on the Siemens PET scanner HRR+ operated in both 2D and 3D modes. No specific correction was applied for the gamma-rays emitted together with the positrons. As compared to 18F, in studies with 124I there is a small loss of image resolution and contrast, and an increase in background. The quantitative results varied between different scanners and various acquisition as well as reconstruction modes, with an average relative difference of -6 +/- 13% (mean+/-SD) in respect of the phantom radioactivity as measured with gamma-ray spectroscopy. We conclude that quantitation of a radiopharmaceutical labelled with 124I is feasible and may be improved by the development of specific corrections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11993941     DOI: 10.1016/s0969-8043(01)00283-4

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  16 in total

1.  Assessment of the short-lived non-pure positron-emitting nuclide (120)I for PET imaging.

Authors:  H Herzog; S M Qaim; L Tellmann; S Spellerberg; D Kruecker; H H Coenen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-15       Impact factor: 9.236

2.  (124)I in PET imaging: impact on quantification, radiopharmaceutical development and distribution.

Authors:  Andreas Bockisch; Lutz Freudenberg; Sandra Rosenbaum; Walter Jentzen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11       Impact factor: 9.236

3.  Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.

Authors:  David Dingli; Brad J Kemp; Michael K O'Connor; John C Morris; Stephen J Russell; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2006 Jan-Feb       Impact factor: 3.488

4.  Optimization and assessment of quantitative 124I imaging on a Philips Gemini dual GS PET/CT system.

Authors:  Rebecca A Gregory; Claire A Hooker; Mike Partridge; Glenn D Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-14       Impact factor: 9.236

5.  Effect of the positron range of 18F, 68Ga and 124I on PET/CT in lung-equivalent materials.

Authors:  Gerrit J Kemerink; Mariëlle G W Visser; Renee Franssen; Emiel Beijer; Mariangela Zamburlini; Servé G E A Halders; Boudewijn Brans; Felix M Mottaghy; Gerrit J J Teule
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

Review 6.  Sub-Nyquist acquisition and constrained reconstruction in time resolved angiography.

Authors:  Charles A Mistretta
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

7.  Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.

Authors:  Scott M Knowles; Kirstin A Zettlitz; Richard Tavaré; Matthew M Rochefort; Felix B Salazar; David B Stout; Paul J Yazaki; Robert E Reiter; Anna M Wu
Journal:  J Nucl Med       Date:  2014-02-06       Impact factor: 10.057

Review 8.  Quantitative imaging of 124I and 86Y with PET.

Authors:  Mark Lubberink; Hans Herzog
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

9.  Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.

Authors:  Walter Jentzen; Reiner Weise; Jürgen Kupferschläger; Lutz Freudenberg; Wolfgang Brandau; Ronald Bares; Wolfgang Burchert; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-10       Impact factor: 9.236

10.  Improved quantification for local regions of interest in preclinical PET imaging.

Authors:  J Cal-González; S C Moore; M-A Park; J L Herraiz; J J Vaquero; M Desco; J M Udias
Journal:  Phys Med Biol       Date:  2015-09-03       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.